-
Je něco špatně v tomto záznamu ?
Active site complementation and hexameric arrangement in the GH family 29; a structure-function study of α-l-fucosidase isoenzyme 1 from Paenibacillus thiaminolyticus
T. Kovalová, T. Koval, E. Benešová, P. Vodicková, V. Spiwok, P. Lipovová, J. Dohnálek,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
Medline Complete (EBSCOhost)
od 1996-01-01 do Před 1 rokem
PubMed
30544181
DOI
10.1093/glycob/cwy078
Knihovny.cz E-zdroje
- MeSH
- alfa-L-fukosidasa chemie genetika MeSH
- bakteriální proteiny chemie genetika MeSH
- katalytická doména MeSH
- krystalografie rentgenová MeSH
- mutace MeSH
- Paenibacillus enzymologie genetika MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
α-l-Fucosidase isoenzyme 1 from bacterium Paenibacillus thiaminolyticus is a member of the glycoside hydrolase family GH29 capable of cleaving l-fucose from nonreducing termini of oligosaccharides and glycoconjugates. Here we present the first crystal structure of this protein revealing a novel quaternary state within this family. The protein is in a unique hexameric assembly revealing the first observed case of active site complementation by a residue from an adjacent monomer in this family. Mutation of the complementing tryptophan residue caused changes in the catalytic properties including a shift of the pH optimum, a change of affinity to an artificial chromogenic substrate and a decreased reaction rate for a natural substrate. The wild-type enzyme was active on most of the tested naturally occurring oligosaccharides and capable of transglycosylation on a variety of acceptor molecules, including saccharides, alcohols or chromogenic substrates. Mutation of the complementing residue changed neither substrate specificity nor the preference for the type of transglycosylation acceptor molecule; however, the yields of the reactions were lower in both cases. Maltose molecules bound to the enzyme in the crystal structure identified surface carbohydrate-binding sites, possibly participating in binding of larger oligosaccharides.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012045
- 003
- CZ-PrNML
- 005
- 20190411132354.0
- 007
- ta
- 008
- 190405s2019 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/glycob/cwy078 $2 doi
- 035 __
- $a (PubMed)30544181
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kovalová, Terézia $u Laboratory of Structure and Function of Biomolecules, Institute of Biotechnology of the Czech Academy of Sciences, v.v.i., Biocev, Vestec, Czech Republic. Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Czech Republic.
- 245 10
- $a Active site complementation and hexameric arrangement in the GH family 29; a structure-function study of α-l-fucosidase isoenzyme 1 from Paenibacillus thiaminolyticus / $c T. Kovalová, T. Koval, E. Benešová, P. Vodicková, V. Spiwok, P. Lipovová, J. Dohnálek,
- 520 9_
- $a α-l-Fucosidase isoenzyme 1 from bacterium Paenibacillus thiaminolyticus is a member of the glycoside hydrolase family GH29 capable of cleaving l-fucose from nonreducing termini of oligosaccharides and glycoconjugates. Here we present the first crystal structure of this protein revealing a novel quaternary state within this family. The protein is in a unique hexameric assembly revealing the first observed case of active site complementation by a residue from an adjacent monomer in this family. Mutation of the complementing tryptophan residue caused changes in the catalytic properties including a shift of the pH optimum, a change of affinity to an artificial chromogenic substrate and a decreased reaction rate for a natural substrate. The wild-type enzyme was active on most of the tested naturally occurring oligosaccharides and capable of transglycosylation on a variety of acceptor molecules, including saccharides, alcohols or chromogenic substrates. Mutation of the complementing residue changed neither substrate specificity nor the preference for the type of transglycosylation acceptor molecule; however, the yields of the reactions were lower in both cases. Maltose molecules bound to the enzyme in the crystal structure identified surface carbohydrate-binding sites, possibly participating in binding of larger oligosaccharides.
- 650 _2
- $a bakteriální proteiny $x chemie $x genetika $7 D001426
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a Paenibacillus $x enzymologie $x genetika $7 D056507
- 650 _2
- $a alfa-L-fukosidasa $x chemie $x genetika $7 D005644
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Koval, Tomáš $u Laboratory of Structure and Function of Biomolecules, Institute of Biotechnology of the Czech Academy of Sciences, v.v.i., Biocev, Vestec, Czech Republic.
- 700 1_
- $a Benešová, Eva $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Czech Republic.
- 700 1_
- $a Vodicková, Patricie $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Czech Republic.
- 700 1_
- $a Spiwok, Vojtech $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Czech Republic.
- 700 1_
- $a Lipovová, Petra $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Czech Republic.
- 700 1_
- $a Dohnálek, Jan $u Laboratory of Structure and Function of Biomolecules, Institute of Biotechnology of the Czech Academy of Sciences, v.v.i., Biocev, Vestec, Czech Republic.
- 773 0_
- $w MED00001937 $t Glycobiology $x 1460-2423 $g Roč. 29, č. 1 (2019), s. 59-73
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30544181 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190411132412 $b ABA008
- 999 __
- $a ok $b bmc $g 1391355 $s 1050350
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 29 $c 1 $d 59-73 $i 1460-2423 $m Glycobiology $n Glycobiology $x MED00001937
- LZP __
- $a Pubmed-20190405